ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag faculty governance disease medicine microbiology

qPCRDriving Wastewater Surveillance for Infectious Disease
Nathan Ni, PhD | Oct 30, 2023 | 3 min read
Natalie Knox and the Public Health Agency of Canada’s National Microbiology Laboratory are helping establish a national qPCR-driven wastewater surveillance network for SARS-CoV-2 and other diseases.
Four glass vials sit on a reflective tabletop next to a syringe. Each is labeled as a subsequent dose in a four-dose series of COVID-19 vaccines.
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines
Dan Robitzski | Aug 11, 2022 | 10+ min read
Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited.
masked teacher sitting on floor showing masked students something on a tablet
Does Science Support Lifting School Mask Mandates?
Rachael Moeller Gorman | Feb 28, 2022 | 10+ min read
The CDC has given the OK to lift indoor mask mandates in much of the US, and a growing number of states no longer require face coverings in schools. But most experts agree that masks slow school spread of SARS-CoV-2, and whether now is the right time to allow teachers and students to unmask is a matter of debate.
Updated Mar 8
A healthcare worker holds up three syringes with clear medicine
To Booster or Not: Scientists and Regulators Debate
Jef Akst | Sep 16, 2021 | 7 min read
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
Of Cells and Limits
Anna Azvolinsky | Mar 1, 2015 | 9 min read
Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.
Neglected diseases: Teach or treat?
Megan Scudellari | May 17, 2010 | 3 min read
Scientists are taking the debate over how to address neglected tropical diseases to the pages of PLoS Medicine, with one camp arguing in favor of more drug development, and another pushing for more funding and research on public health strategies such as sanitation and education. In 2005, researchers coined the term "neglected tropical diseases" to refer to thirteen diseases primarily occurring in rural, poor areas that have been largely ignored by policymakers and public health officials. Thes
Broadening Applicability Fosters Growth In Microbiology's Current Job Market
Marcia Clemmitt | May 16, 1993 | 8 min read
Life scientists are increasingly adopting the belief that microorganisms are virtually everywhere and are responsible for just about everything. This, plus the maturation of molecular- level methods of working with these tiny creatures, is a source of considerable optimism for microbiologists as the 93rd general meeting of the American Society for Microbiology (ASM) convenes in Atlanta this week. What they see, in career terms, is that progress in their field is bound to yield an ever-widening
n95 mask coronavirus covid-19 sars-cov-2 ppe personal protective equipment face shield respirator virology research lab scientists
Some Coronavirus Researchers Are Running Low on Masks
Katarina Zimmer | Apr 1, 2020 | 7 min read
A large-scale shortage of respirators and face shields threatens progress in some labs that are currently trying to ramp up their studies of SARS-CoV-2.
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th

Run a Search

ADVERTISEMENT